Finance

Lists
4521:TYO
Kaken Pharmaceutical Co Ltd
3 785,00 JP¥
-0,39%
(-15,00) 1D
14 հոկ, 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4521...
Open
3 770 JP¥
High
3 800 JP¥
Low
3 760 JP¥
Mkt. cap
167,07 մլրդ
Avg. vol.
110,37 հզր
Volume
71,70 հզր
Dividend
5,02%
Quarterly dividend
47 JP¥
Ex-dividend date
29 սեպ, 2026 թ.
P/E ratio
13,90
52-wk high
4 445 JP¥
52-wk low
3 540 JP¥
EPS
272 JP¥
Shares outstanding
39,72 մլն
No. of employees
1 հզր
Open
3 770 JP¥
High
3 800 JP¥
Low
3 760 JP¥
Mkt. cap
167,07 մլրդ
Avg. vol.
110,37 հզր
Volume
71,70 հզր
Dividend
5,02%
Quarterly dividend
47 JP¥
Ex-dividend date
29 սեպ, 2026 թ.
P/E ratio
13,90
52-wk high
4 445 JP¥
52-wk low
3 540 JP¥
EPS
272 JP¥
Shares outstanding
39,72 մլն
No. of employees
1 հզր
News stories
From web sources and news partners
About Kaken Pharmaceutical Co Ltd
CEO-
Employees1,11 հզր
Founded1917
Headquarters-
Sector-
Websitekaken.co.jp
Last report
07 օգս, 2026 թ.
Fiscal period
Q1 2027
- / -
Revenue / Est. (JPY)
30,16 մլրդ / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
20,49 մլրդ
18,26 մլրդ
19,25 մլրդ
30,16 մլրդ
Cost of goods sold
8,78 մլրդ
9,01 մլրդ
10,09 մլրդ
9,18 մլրդ
Cost of revenue
8,78 մլրդ
9,01 մլրդ
10,09 մլրդ
9,18 մլրդ
Research and development expenses
6,29 մլրդ
3,97 մլրդ
4,94 մլրդ
4,60 մլրդ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,23 մլրդ
4,92 մլրդ
4,92 մլրդ
5,47 մլրդ
Operating expense
11,52 մլրդ
8,90 մլրդ
10,62 մլրդ
10,07 մլրդ
Total operating expenses
20,30 մլրդ
17,91 մլրդ
20,71 մլրդ
19,25 մլրդ
Operating income
187,00 մլն
354,00 մլն
-1,46 մլրդ
10,90 մլրդ
Other non operating income
-27,00 մլն
34,00 մլն
43,00 մլն
8,00 մլն
EBT including unusual items
988,00 մլն
588,00 մլն
328,00 մլն
11,24 մլրդ
EBT excluding unusual items
184,00 մլն
598,00 մլն
-1,41 մլրդ
11,26 մլրդ
Income tax expense
267,00 մլն
182,00 մլն
-418,00 մլն
2,80 մլրդ
Effective tax rate
27,02%
-
-127,44%
24,93%
Other operating expenses
-
-
-
-
Net income
721,00 մլն
406,00 մլն
746,00 մլն
8,44 մլրդ
Net profit margin
3,52%
-
3,87%
27,99%
Earnings per share
-
-
-
-
Interest and investment income
78,00 մլն
324,00 մլն
91,00 մլն
393,00 մլն
Interest expense
-11,00 մլն
-11,00 մլն
-13,00 մլն
-14,00 մլն
Net interest expenses
67,00 մլն
313,00 մլն
78,00 մլն
379,00 մլն
Depreciation and amortization charges
-
-
752,00 մլն
-
EBITDA
922,00 մլն
992,50 մլն
-624,75 մլն
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps